Angiodynamics (ANGO) Inventory Average (2011 - 2026)

Angiodynamics' Inventory Average history runs 16 years deep, the most recent figure standing at $55.5 million for Q2 2026.

• Quarterly Inventory Average fell 11.27% year-over-year to $55.5 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $55.5 million (down 11.27% YoY) and the FY2026 annual result came in at $57.2 million, down 6.67% from the prior year.
• Inventory Average was $55.5 million for Q2 2026 at Angiodynamics, down from $62.1 million in the prior quarter.
• Across five years, Inventory Average topped out at $65.3 million in Q4 2024 and bottomed at $48.1 million in Q1 2022.
• A 5-year average of $59.7 million and a median of $61.6 million in 2024 frame the typical range for Inventory Average.
• Annual changes were most pronounced in 2023 — Inventory Average jumped 31.68% — and 2026, when it fell 11.27%.
• Angiodynamics' Inventory Average stood at $60.4 million in 2022, then gained by 2.85% to $62.1 million in 2023, then rose by 5.15% to $65.3 million in 2024, then retreated by 2.14% to $63.9 million in 2025, then declined by 13.15% to $55.5 million in 2026.
• Business Quant data shows ANGO's Inventory Average at $55.5 million in Q2 2026, $62.1 million in Q1 2026, and $63.9 million in Q4 2025.